The CVOT Summit celebrates 10 years of advancing care in type 2 diabetes, highlighting breakthroughs in CV, kidney, and metabolic outcome trials. Since CVOTs became mandatory in 2008, new drug classes like SGLT2is, GLP-1 RAs, and finerenone have reshaped treatment strategies.